Associated Papers
Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial.
Tucker BA et al.
Translational Research : the Journal of Laboratory and Clinical Medicine, 2015
Select a paper to view details